Wolters Kluwer JBI Resources on Ovid is an institutional evidence-based practice platform that provides access to JBI evidence summaries and procedures, systematic review workflow software (SUMARI), and implementation/audit tooling (PACES with GRiP) delivered via the Ovid platform.
Published May 16, 2026
| Starting Price | Quote-based (institutional; not publicly listed) | Published individual/student pricing referenced publicly; clinician plans vary; institutional quote-based | Individual subscription options exist; institutional quote-based; public pages emphasize subscription options but do not provide a universal institutional price |
| Primary fit | Institutions building an organized EBP capability across content, systematic review production, and implementation/audit workflows (especially nursing/allied health and QI teams) | Clinical decision support with evidence summaries and integrated drug information; clinician workflows focus | Physician-focused topic answers with clinician-oriented nuance and workflow integration |
| Key strength | Integrated EBP content plus aligned tooling for appraisal and application, coupled with JBI methodology alignment | Point-of-care orientation and curated clinical summaries; vendor positions product for clinician workflows | Broad physician-focused content and established clinician adoption; vendor also markets AI-enhanced features |
| Key weakness | Limited independent product-level review volume in public sources; pricing opacity; PACES is online-only | Organizations accustomed to a different point-of-care provider may experience switching friction; subjective clinician preferences on nuance may vary | Cost sensitivity and occasional price-increase concerns in clinician communities; institutional budget pressure |
—
JBI-on-Ovid versus point-of-care tools JBI-on-Ovid differs from pure point-of-care tools by combining evidence summaries with systematic review production (SUMARI) and implementation/audit workflows (PACES/GRiP). Organizations focused primarily on rapid bedside clinical answers may prefer dedicated point-of-care tools. Organizations seeking an organized institutional EBP capability that includes training, review production, and implementation workflows may find the combined offering more aligned.
Systematic review tooling competitors (Covidence/DistillerSR) SUMARI is aligned with JBI methodology and offers report-building exports. Covidence and DistillerSR may have adoption advantages in certain academic communities, a different integration footprint (reference managers, PRISMA workflows), and established familiarity among review teams.
Quality improvement tooling competitors PACES' integration with JBI evidence resources and GRiP is a differentiator in methodology alignment. However, many QI efforts use spreadsheets, QI templates, or broader enterprise QI platforms that may offer more customization, enterprise analytics, or offline/mobile capabilities.